- Home
- NXTC vs FEBO Comparison
NXTC vs FEBO Comparison
Compare NXTC & FEBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXTC
- FEBO
- Stock Information
- Founded
- NXTC 2015
- FEBO 1993
- Country
- NXTC United States
- FEBO Hong Kong
- Employees
- NXTC N/A
- FEBO N/A
- Industry
- NXTC Biotechnology: Pharmaceutical Preparations
- FEBO
- Sector
- NXTC Health Care
- FEBO
- Exchange
- NXTC Nasdaq
- FEBO Nasdaq
- Market Cap
- NXTC 13.9M
- FEBO 12.6M
- IPO Year
- NXTC 2019
- FEBO 2023
- Fundamental
- Price
- NXTC $0.45
- FEBO $1.09
- Analyst Decision
- NXTC Strong Buy
- FEBO
- Analyst Count
- NXTC 2
- FEBO 0
- Target Price
- NXTC $3.50
- FEBO N/A
- AVG Volume (30 Days)
- NXTC 346.6K
- FEBO 8.7K
- Earning Date
- NXTC 07-31-2025
- FEBO 07-15-2025
- Dividend Yield
- NXTC N/A
- FEBO N/A
- EPS Growth
- NXTC N/A
- FEBO N/A
- EPS
- NXTC N/A
- FEBO N/A
- Revenue
- NXTC N/A
- FEBO $17,110,653.00
- Revenue This Year
- NXTC N/A
- FEBO N/A
- Revenue Next Year
- NXTC N/A
- FEBO N/A
- P/E Ratio
- NXTC N/A
- FEBO N/A
- Revenue Growth
- NXTC N/A
- FEBO 11.58
- 52 Week Low
- NXTC $0.22
- FEBO $0.93
- 52 Week High
- NXTC $1.82
- FEBO $17.68
- Technical
- Relative Strength Index (RSI)
- NXTC 44.08
- FEBO 40.32
- Support Level
- NXTC $0.45
- FEBO $1.01
- Resistance Level
- NXTC $0.49
- FEBO $1.26
- Average True Range (ATR)
- NXTC 0.06
- FEBO 0.07
- MACD
- NXTC -0.01
- FEBO -0.00
- Stochastic Oscillator
- NXTC 0.74
- FEBO 2.00
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.
About FEBO Fenbo Holdings Limited
Fenbo Holdings Ltd is a company engaged in producing premium personal care electric appliances, principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.